Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 678-686

  Gadano, Adriaán C ^a   Sogni, Philippe ^a   Yang, Song ^a   Cailmail, Stéphanie ^a   Moreau, Richard ^a   Nepveux, Paul ^b   Couturier, Daniel ^b   Lebrec, Didier ^a  

^a Lab d'Hemodynamique Splanchnique   (France)

^b Université Paris Descartes   (France)

Author keywords

calmodulin; nitric oxide synthase isoforms; portal hypertension; vascular reactivity

Indexed keywords

ACETYLCHOLINE; CALMIDAZOLIUM; CALMODULIN; INDOMETACIN; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; ENDOTHELIUM; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT;

EID: 0031047234     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80435-7     Document Type: Article

References (42)

1. Bomzon A. Vascular reactivity in liver disease. Bomzon A, Blendis LM. Cardiovascular Complications of Liver Disease. 1990;207-224 CRC Press, Boca Raton.
2. Groszmann HJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 20:1994;1359-1363.
3. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology. 20:1994;1343-1350.
4. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome assoiated with portal hypertension. J Hepatol. 23:1995;218-224.
5. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D. role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic portal hypertension. Hepatology. 18:1993;621-627.
6. Sitzmann JV, Bulkley GB, Mitchell MC, Campbell K. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg. 209:1989;322-327.
7. Wu Y, Cartland Burns R, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamis in portal hypertension. Hepatology. 18:1993;1416-1421.
8. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem. 269:1994;13725-13728.
9. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1989;664-666.
10. Forstermann U, Pollock JS, Schmidt HHHW, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA. 88:1991;1788-1792.
11. Busse R, Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265:1990;133-136.
12. Miller VM, Aarhus LL, Vanhoutte PM. Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol. 251:1986;H250-H257.
13. Busse R, Mulsch A. Induction of nitric oxyde synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 265:1990;87-90.
14. Schini VB, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun. 176:1991;114-121.
15. Schini VB, Vanhoutte PM. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. J Pharmacol Exp Ther. 261:1992;553-559.
16. Halvorsen JF, Myking AO. Prehepatic portal hypertension in the rat. Immediate and long-term effects on portal vein and aortic pressure of a graded portal vein stenosis, followed by occlusion of the portal vein and spleno-renal collaterals. Eur Surg Res. 11:1974;89-98.
17. Lee SS, Girod C, Valla D, Geoffroy P, Lebrec D. Effects of pentobarbital sodium anesthesia on splanchnic hemodynamics of normal and portal-hypertensive rats. Am J Physiol. 249:1985;G528-G532.
18. w-Nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 176:1990;219-223.
19. Flower RJ. Drugs which inhibit prostaglandin synthesis. Pharmacol Rev. 26:1974;33-63.
20. Jeremy JY, Mikhailidis DP, Dandona AP. Differential inhibitory potencies on non-steroidal antiinflammatory drugs on smooth muscle prostanoid synthesis. Eur J Pharmacol. 182:1990;83-89.
21. Cawley T, Geraghty J, Osborne EH, Docherty JR. Effects of portal hypertension on responsiveness of rat mesenteric arter y and aorta. Br J Pharmacol. 114:1995;791-796.
22. Karatapanis S, McCormick PA, Kakad S, Chin JKT, Islam M, Jeremy J, Harry D, McIntyre N, Burroughs A, Joacobs M. Alteration in vascular reactivity in isolatedaortic rings from portal vein-constricted rats. Hepatology. 20:1994;1516-1521.
23. Castro A, Jiménez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, Piulats J, Rivera F, Rodés J. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology. 18:1993;367-372.
24. Claria J, Jiménez W, Ros J, Rigol M, Angelia P, Arroyo V, Rivera F, Rodés J. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology. 20:1994;1615-1621.
25. Sieber CC, Groszmann RJ. Nitric oxide mediates in vitro hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 103:1992;235-239.
26. Sogni P, Sabry S, Chabot F, Moreau R, Gadano A, Lebrec D, Dinh-Xuan AT. Hyporeactivity of mesenteric resitance arteries in portal hypertensive rats. J Hepatol. 24:1996;487-490.
27. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet. 337:1991;776-778.
28. Hidaka H, Asano M, Iwadare S, Matsumoto I, Totsuka T, Aoki N. A novel vascular relaxing agent, N-(6-aminohexyl)-5-chloro-1-naphthalensulfonamide which affects vascular smooth muscle actomyosin. J Pharmacol Exp Ther. 207:1978;8-15.
29. ++-transport ATPase and of calmodulin-regulated functions. Biochem Biophys Res Commun. 101:1981;418-425.
30. Hidaka H, Yamaki T, Naka M, Tanaka T, Hayashi H, Kobayashi R. Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase. Mol Pharmacol. 17:1980;66-72.
31. Weinheimer G, Osswald H. Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists. Naunyn-Schmeideberg's Arch Pharmacol. 332:1986;391-397.
32. Michielsen P, Boeckxstaens G, Sys S, Herman A, Pelckmans P. Role of nitric oxide in hyporeactivity to noreadrenaline of isolated aortic rings in portal hypertensive rats. Eur J Pharmacol. 273:1995;167-174.
33. Cahill PA, Foster C, Redmond E, Gingalewski C, Wu YP, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypetensive rabbits. Hepatology. 22:1995;598-606.
34. Martin P, Ding L, Niedeberger M, Weigert A, Tsai P, St John J, Ginès P, Schrier R. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol. 270:1996;F494-F499.
35. Fernandez M, Garcia Pagan JC, Casadevall AM, Bernadich C, Piera C, Whittle BJ, Piqué JM, Bosch J, Rodés J. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology. 108:1995;1487-1495.
36. Weigert AL, Niederberger M, Ginés P, Martin PY, Higa EMS, McMurtry If, Schrier RW. Endothelium-dependent vascular hyporesponsiveness without nitric oxide synthase induction in aortas of cirrhotic rats (Abstract). Hepatology. 20:1994;6A.
37. Soubrane O, Lacronique V, Miquerol L, Mignon A, Houssin D. The role of inducible NO synthase (iNOS) in the hyperdynamic circulation of portal hypertension (Abstract). Hepatology. 22:1995;156A.
38. Morales M, Jimenez W, Ros J, Leivas A, Perez-Sala D, Lamas S, Arroyo V, Rivera F, Rodés J. Transcriptional activation of inducible nitric oxide synthase in arterial vessels of cirrhotic rats (Abstract). Hepatology. 22:1995;155A.
39. Lopez Talavera JC, Groszmann RJ. Treatment with aminoguanidine, a specific inhibitor of the inducible nitric oxide synthase, ameliorates the hyperdynamic syndrome in portal hypertensive rats (Abstract). Hepatology. 20:1994;143A.
40. Heinemann A, Stauber RE. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J Pharmacol. 278:1995;87-90.
41. 2+ release from internal stores in neuronal cell line is enhanced by cyclic AMP. Eur J Pharmacol. 277:1992;89-93.
42. Kuhn M, Otten A, Frolich J, Fostermann U. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor-nitric oxide from bovine aortic endothelial cells. J Pharmacol Exp Ther. 256:1991;677-682.